In-Vivo Activated T-Cell Depletion to Prevent GVHD
Sponsor: Indiana University
Terminated
Treatment ineffective
Other terminated trials from Indiana University
Other Acute Lymphocytic Leukemia trials with similar outcome
Listed as NCT00594308, this NA trial focuses on Acute Lymphocytic Leukemia and Acute Myelogenous Leukemia and remains terminated or withdrawn. Sponsored by Indiana University, it has been updated 8 times since 2007, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2023 — Jul 2024 [monthly]
Terminated NA
-
Dec 2022 — Jan 2023 [monthly]
Terminated NA
-
Dec 2021 — Dec 2022 [monthly]
Terminated NA
▶ Show 3 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
Jan 2017 — Jun 2018 [monthly]
Terminated NA
First recorded
Oct 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Indiana University
For direct contact, visit the study record on ClinicalTrials.gov .